The tumult of large-scale cuts to federal spending, pullbacks of civil rights protections, and new tariffs getting announced ...
Further information on the abstracts that Roche will present at MDA 2025 can be found below.
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.
Industry leaders say government failed to protect Thomas Cooper from dying in a hyperbaric chamber fire at the Oxford Center in Troy.
While we're not short of divisive topics in 2025, there are valid reasons as to why we're turning to chatbots for emotional ...
This kind of disillusionment can be painful, but there are ways to manage the feelings of betrayal and anguish.
Sometimes, people are shocked when I say pediatric cancer is a rare disease, but it’s true. In the United States, ...
23h
MyChesCo on MSNThird Arc Bio Enters Clinical Stage with First Patient Dosed in ARC101 StudyHOUSE, PA — Third Arc Bio Inc. has administered the first dose of ARC101 to a patient in its inaugural first-in-human ...
In Season 3 of the HBO series "The White Lotus," some characters pop lorazepam like candy, highlighting the potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results